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ABSTRACT
Background: Differential expression of chemokine genes were investigated in various types of ocular surface
cells.
Methods: Primary cultures of human corneal epithelial cells (n = 3), corneal fibroblasts (n = 2), conjunctival
epithelial cells (n = 2) and conjunctival fibroblasts (n = 2) were established and incubated with or without inter-
leukin (IL)-4 (30 ngml) and tumor necrosis factor (TNF)-α (30 ngml) for 24 hours. Gene transcription levels of
33 chemokines and production of 4 chemokines were analyzed.
Results: After stimulation, chemokine expression increased for 18 of 33 coded chemokine gene transcripts. In
stimulated conjunctival and corneal cells, CC chemokine genes increased in fibroblasts (expression of 6 out of
8 genes), while CXC chemokine genes increased in both epithelial cells (expression of 4 out of 9 genes in con-
junctival epithelial cells and 7 out of 9 genes in corneal epithelial cells) and in fibroblasts (expression of 8 out of
9 genes in conjunctival and corneal fibroblasts). Except for MCP-1, gene transcription levels for most CC
chemokines were inducible and, except for IP-10 and I-TAC, most CXC chemokines were constitutively ex-
pressed. Corneal epithelial cell and fibroblast production patterns for eotaxin-1, MCP-1 and IP-10 were compa-
rable to the mRNA expression pattern.
Conclusions: Corneal and conjunctival fibroblasts exhibited marked increases in the expression of chemoki-
nes upon stimulation with TNF-α and IL-4, suggesting that fibroblasts may be one of the primary sources of
chemokines in allergic conjunctival diseases. Therefore, regulation of chemokine production from these cells
may be an effective strategy for treating such diseases.
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INTRODUCTION
Allergic inflammation may be augmented by many
types of inflammatory cells recruited by the ocular
surface cells, such as T cells, eosinophils and neutro-
phils. Chemokines undoubtedly play major roles in
the recruitment of these inflammatory cells.1-3 Ocular
tissue constituent cells along with tissue resident
mast cells and recruited inflammatory cells are
thought to be the major sources of these chemoki-
nes.4,5
In 1993, interleukin (IL)-8 production from corneal
epithelial cells was first reported,6 followed by several
reports on IL-8 production from corneal fibroblasts7
and conjunctival epithelial cells.8,9
In 1995, “regulated upon activation, normal T cell
expressed and secreted” (RANTES) was reported to
occur in the tears of allergic conjunctivitis patients.10
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We have previously reported that eotaxin-1 concen-
trations in tears correlate with the severity of allergic
corneal damage.11 These findings suggest CC
chemokine involvement in the pathogenesis of the
eosinophilic tissue damage in allergic conjunctival
diseases.12 Although we have previously reported
that anti-CC chemokine receptor (CCR) 3 and anti-
CCR1 antibody suppressed eosinophil chemotaxis in-
duced by tear samples, this suppression was not com-
plete.13 This suggests that in addition to eotaxin-1 and
RANTES, other chemokines or factors are also pre-
sent in tears and contribute to eosinophil recruit-
ment.
Primary cultures and cell lines of corneal and con-
junctival cells have been widely used in studies on
CC chemokine production.7,14,15 We have reported
that IL-4 and tumor necrosis factor (TNF)-α induced
eotaxin-1 production in corneal fibroblasts, but not in
corneal epithelial cells.5 Although there may be dif-
ferences in chemokine production patterns between
the cell types, comprehensive studies on chemokine
production from ocular surface constituent cells have
yet to be reported.
The chemokine production profile of the ocular
surface constituent cells is of great interest to oph-
thalmologists, as this has the potential to lead to new
treatment strategies directed towards suppressing
chemokine production or towards blocking
chemokine receptors in allergic tissue.2 In this study,
we used high-density oligonucleotide probe arrays
(GeneChipⓇ) and an enzyme-linked immunosorbent
assay (ELISA) to investigate comprehensive
chemokine gene expression and production in pri-
mary cultures of corneal epithelial cells, corneal fibro-
blasts, conjunctival epithelial cells and conjunctival fi-
broblasts.
METHODS
CULTURE OF HUMAN CORNEAL EPITHELIAL
CELLS AND FIBROBLASTS
Human corneas were obtained from the American
Eye Bank Association. Cultures of human corneal epi-
thelial cells (n = 3 for gene chip and n = 3 for ELISA)
were established as has been previously reported.16
In brief, corneas with adjacent limbus were dissected
into small pieces and cultured in collagen-coated 35-
mm culture dishes (Iwaki Co., Tokyo, Japan) in sup-
plemental hormonal epithelial medium (SHEM).17
The medium consisted of an equal volume of 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HE-
PES)-buffered Dulbecco’s Modified Eagle’s Medium
(DMEM) and Ham’s F12, which contained bicarbon-
ate, 0.5% dimethyl sulfoxide, 10 ngmL human EGF,
5 ugmL insulin, 0.1 ugmL cholera toxin A subunit,
10% fetal calf serum (FCS), and penicillin G-str-
eptomycin. Cultures were performed using standard
conditions (37℃, 95% humidified air and 5% CO2) un-
til confluence was obtained.
Human corneal fibroblasts were established in cul-
ture (n = 2 for gene chip and n = 3 for ELISA) as de-
scribed by Cubitt et al.6 In brief, dissected corneal
pieces were cultured in DMEMF12 (1 : 1 mixture of
DMEM and Ham’s F12; Gibco, Grand Island, NY,
USA) with 10% FCS on collagen-coated 35-mm cul-
ture dishes (Iwaki Co.).
Cultured cells were studied between the third and
fifth passages. Purity of each cell type was assessed
by cell morphology and differential activities towards
anti-cytokeratin antibodies; i.e., corneal fibroblasts
were positive for anti-vimentin antibodies (Boehr-
inger Mannheim, Indianapolis, IN, USA), but not anti-
keratin AE1AE3 (Progen Biotechnik GmbH, Heidel-
berg, Germany).
CULTURES OF HUMAN CONJUNCTIVAL EPI-
THELIAL CELLS AND FIBROBLASTS
All human subjects in this study provided written in-
formed consent. The study was approved by the Ethi-
cal Review Board at the Tokyo Dental College
Ichikawa Hospital (Chiba, Japan) and adhered to the
principles embodied in the Declaration of Helsinki of
1995 (as revised in Edinburgh 2000). Approximately
1×3 mm of conjunctival tissue was obtained during
chalazion or cataract operations. Primary cultures of
conjunctival epithelial cells (n = 2) and fibroblasts (n
= 2) were established as corneal epithelial cells and fi-
broblasts, as described above.
ACTIVATION OF CORNEAL AND CONJUNCTI-
VAL CELLS
At the third to fifth passage, cells were removed from
the culture dishes by diluting the cultures (1 : 4) with
0.25% trypsin-ethylenediaminetetraacetic acid (tryp-
sin-EDTA) (Sigma, St. Louis, MO, USA) in phos-
phate-buffered saline (PBS). Corneal and conjunctival
fibroblasts were resuspended with DMEMF12 con-
taining 10% FCS and preincubated overnight in 150-
cm2 flasks for the gene chip experiments (5×106
cellsflask) or on 96-well culture plates for the ELISA
assay (1×104 cellswell). Epithelial cells were resus-
pended with SHEM medium containing 10% FCS and
preincubated overnight in 75-cm2 flasks for the gene
chip experiments (1×107 cellsflask) or on 96-well cul-
ture plates for the ELISA assay (5×104 cellswell). Af-
ter washing with PBS, the culture medium was
changed to DMEM without FCS for the next 24
hours.
Cells were then incubated with recombinant (r) hu-
man (h) IL-4 (R&D Systems, Minneapolis, MN, USA)
(30 ngmL) and rhTNF-α (R&D Systems) (30 ng
mL) for 24 hours. Samples were collected by pipet-
ting, with the remaining cells removed by centrifuga-
tion at 15000 rpm for 5 minutes. The RNeasy Mini Kit
(Qiagen, Valencia, CA, USA) was used to obtain the
total RNA from the collected cells, after which the
samples were stored at −20℃ until performance of
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further gene chip analysis.
For ELISA, cells were incubated with the combina-
tions of IL-4 (0.3, 3, 30 ngml) and TNF-α (0.3, 3, 30
ngmL) for 48 hours. Supernatants were stored at
−70℃ until further ELISA assays were performed.
OLIGONUCLEOTIDE ARRAY SEQUENCE ANA-
LYSIS
The Human Genome U95A probe array (GeneChipⓇ,
Affymetrix, Santa Clara, CA, USA), which contains an
oligonucleotide probe set for approximately 12,000
full-length genes, was used to examine the human
genome-wide gene expression in accordance with the
manufacturer’s protocol (Expression Analysis Techni-
cal Manual) and a previous report.18
Total RNA (5 μg) was extracted from approxi-
mately 107 cells. Double-stranded cDNA was synthe-
sized using a SuperScript Choice System (Life Tech-
nologies, Rockville, MD, USA) and a T7-(dT) 24
primer (Amersham Pharmacia Biotech, Buckingham-
shire, UK). The cDNA was subjected to in vitro tran-
scription in the presence of biotinylated nucleoside
triphosphates using a BioArray High Yield RNA Tran-
script Labeling Kit (Enzo Diagnostics, Inc., Farming-
dale, NY). The biotinylated cRNA was hybridized
with a probe array for 16 hours at 45℃. After wash-
ing, the hybridized biotinylated cRNA was stained
with streptavidin-phycoerythrin (Molecular Probes,
Eugene, OR, USA) and then scanned with a HP Gene
Array Scanner. The fluorescence intensity of each
probe was quantified using a computer program,
GeneChipⓇ Analysis Suite 4.0 (Affymetrix). The ex-
pression level of a single mRNA was determined as
the average fluorescence intensity among the intensi-
ties obtained by 6-20-paired probes (perfect-matched
and single nucleotide-mismatched), and which con-
sisted of 25-base oligonucleotides. If the intensities of
the mismatched probes were extremely high, gene
expression was judged to be absent even if there was
a high average fluorescence obtained with the
GeneChipⓇ Analysis Suite 4.0 program. The
GeneChipⓇ software was employed to determine the
level of the gene expression, which was calculated as
the average difference (AD). The percentages for the
specific AD levels versus the mean AD levels of the
six probe sets for the housekeeping genes (β-actin
and glyceraldehyde-3-phosphate dehydrogenase)
were then calculated.
ELISA FOR CHEMOKINES
Human eotaxin-1, MCP-1, IP-10 and GRO-α concen-
trations were measured by ELISA kits (R&D). The
detection limits of these assay kits were approxi-
mately 3 pgml.
STATISTICAL ANALYSIS
Differences between two paired groups were ana-
lyzed by a paired Student’s t-test with p < 0.05 consid-
ered to be significant. Values are expressed as the
mean ± SD.
RESULTS
ELEVATED TRANSCRIPTS IN ACTIVATED COR-
NEAL AND CONJUNCTIVAL CELLS
We used GeneChipⓇ to examine the expression lev-
els of approximately 12,000 genes in the corneal and
conjunctival cells before and after stimulation with IL-
4 and TNF-α (n = 2-3 for each of the cell types). Fold
increase was obtained by calculating the AD levels of
the activated cells versus those of the resting cells.
The “average fold increase” was obtained by averag-
ing the fold increase for each sample. After elimina-
tion of the redundant transcripts, we selected the 30
most upregulated transcripts for each of the cell
types.
In the conjunctiva, three genes for the CC
chemokines (RANTES, TARC and eotaxin-1) were
listed among the top 30 most increased genes for the
fibroblasts, while only one (RANTES) was noted to
increase in the epithelial cells (Table 1). In the cor-
nea, three genes for the CC chemokines (eotaxin-1,
MCP-2 and RANTES) were among the top 30 most in-
creased genes for the fibroblasts, while only one
(LARC) was observed for the epithelial cells (Table
2).
COMPARISON OF CHEMOKINE GENE EXPRES-
SIONS BETWEEN CELL TYPES
As seen in Table 3, we selected 33 chemokine-
associated genes and 15 chemokine receptor-
associated genes. Fold increases were calculated and
judged as “increased” when there was a two-fold in-
crease in the AD for the stimulated cells.
In both the stimulated conjunctival and corneal
cells, CC chemokine-associated genes primarily in-
creased in the fibroblasts, while CXC chemokine-
associated genes increased in both the epithelial cells
and the fibroblasts. In six out of eight of the “in-
creased” CC chemokine genes, a dominant increase
was noted in the fibroblasts, while in six out of nine of
the “increased” CXC chemokine genes, increases in
both the fibroblasts and the epithelial cells were
noted. In conjunctival cells, one gene for CC
chemokine (RANTES) and four genes for CXC
chemokines (GRO-α, CKA-3, IL-8 and IP-10) were
judged as being “increased” in the epithelial cells,
while six genes for CC chemokines (MCP-1, 2, 4,
RANTES, eotaxin-1 and TARC) and eight genes for
CXC chemokines (GRO-α, β, γ, CKA-3, IL-8, MIG, IP-
10 and I-TAC) were judged as “increased” in the fi-
broblasts. In corneal cells, three genes for the CC
chemokines (RANTES, LARC and TECK) and seven
genes for the CXC chemokines (GRO-α, β, γ, ENA-78,
CKA-3, IL-8, and IP-10) were judged as “increased” in
the epithelial cells, while six genes for the CC
chemokines (MCP-1, 2, 4, RANTES, eotaxin-1, and
Fukagawa K et al.
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Table 1 Top 30 increased transcripts in the conjunctival epithelial cels and fibroblasts
Conjunctival fibroblasts (n=2)Conjunctival epithelial cels (n=2)
Average 
fold 
increase
Accession 
number
Name of transcript (protein)Average 
fold 
increase‡
Accession 
number†
Name of transcript (protein)
6533.9AL031983Diubiquitin2997.3U19557Squamous cel carcinoma antigen 2
2527.8D28137Bone marow stromal cel antigen 2766.2M381803-beta-hydroxysteroid dehydrogenase
2303.4AF026941Viperin (cig5)511.6U49184Occludin
1694.7X02530IP-10382.5U70981Interleukin-13 receptor
1495.3HG544-HT544Endothelial Cel Growth Factor 1362.4X04430IFN-beta 2a mRNA
1467.5AJ2250892-5' oligoadenylate synthetase 344.2U81234CKA-3§
944.3AF030514I-TAC329.9AF030428I cel membrane-associated protein
hT1a-2 
843.8M21121RANTES329.5X96484DGCR6 protein
587.6L40387Thyroid receptor interactor 283.6L37127RNA polymerase I
563.8L23808Metaloproteinase 260.3AF059214Cholesterol 25-hydroxylase
559.2Y00630Plasminogen activator-inhibitor 2254.6L24564Ras associated with diabetes
523.2D38128IP gene for prostacyclin receptor253.1AB000734Tec-interacting proteins-3
464.7AF056732Prostaglandin transporter (SLC21A2)253.0X67325HSP27
461.0U70981Human interleukin-13 receptor236.2Z74792CCAAT transcription binding factor
subunit gamma 
437.5AF030428I cel membrane-associated
protein hT1a-2 
167.1X15880Colagen VI alpha-1 C-terminal
globular domain 
371.5D43767TARC162.9M31165Tumor necrosis factor-inducible
protein (TSG-6)
325.0X72755MIG122.6AB014564KIAA0664 protein
323.4J03910Metalothionein-IG42.5U26710Human cbl-b mRNA
275.6AF029403Oxysterol 7alpha-hydroxylase 41.8J03037Carbonic anhydrase I 
264.2M30257Vascular cel adhesion molecule 1 38.8AF081195Calcium and diacylglycerol-regulated
guanine nucleotide exchange factor I
245.5X78565Tenascin-C32.1U14528Human sulfate transporter of 
Diastrophic dysplasia 
218.4AL050267DKFZp564A03227.8S66896Squamous cel carcinoma antigen
213.5M74447Peptide supply factor-2 27.7M24283ICAM-2
185.7S46950Adenosine A2 receptor21.6X62822Beta-galactoside alpha-2,6- 
sialyltransferase 
173.4J05581Human polymorphic epithelial mucin21.5U21049Membrane-associated protein 17
171.3U88964HEM4513.4U45878Inhibitor of apoptosis protein 1
157.4AB000734TIP311.9AA631972Natural kiler cel transcript 4
156.5X81053Colagen type IV alpha 4 chain 10.9HG1747-
HT1764
Proto-Oncogene Met, Alt. Splice
Form 2
136.0AF015451Usurpin-beta 9.9M21121RANTES
132.7U46573Eotaxin8.6M28130IL8
† The GeneBank accession number (htp:/www.ncbi.nlm.nih.gov/sites/entrez?db=Nucleotide) of each transcript is shown.
‡ The level of gene expression was obtained as the AD (average diference) using GeneChip® software. The percentages of the spe-
cific AD level versus the mean AD level of 6 probe sets for housekeeping genes (beta-actin and glyceraldehede-4-phosphate dehydroge-
nase) were then calculated. The fold increases of each experiment were averaged and are shown as the average fold increase.
§ Data indicating chemokine gene are underlined.
TARC) and eight genes for the CXC chemokines
(GRO-α, β, γ, ENA-78, CKA-3, IL-8, IP-10 and I-TAC)
were judged as “increased” in the fibroblasts. CX3C
chemokine (fractalkine) was judged as “increased” in
both the conjunctival and corneal fibroblasts. Except
for MCP-1, gene transcription levels were inducible
for most CC chemokines and, except for IP-10 and I-
TAC, most CXC chemokines were constitutively ex-
pressed. No gene transcripts for the chemokine re-
ceptors were judged to be “increased”.
Chemokine Expression in Ocular Cells
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Table 2 Top 30 increased transcripts in the corneal epithelial cels and fibroblasts
Corneal fibroblasts (n=2)Corneal epithelial cels (n=3)
Average 
fold 
increase
Accession 
number
Name of transcript (protein)Average 
fold 
increase‡
Accession 
number†
Name of transcript (protein)
7474.7AL031983Diubiquitin2883.1AA631972Natural kiler cel transcript 4 
5479.9U46573Eotaxin2258.7AL031983Diubiquitin
2124.9X02530IP-10735.0M24283Inter celular adhesion molecule-1
1468.4AF030514I-TAC660.2L24564Ras associated with diabetes
1028.0AF000959Claudin5225.8U20816Nuclear factor kappa-B2
791.2Y16645MCP-2 217.0S76638Nuclear factor kappa-B
785.0U70981Interleukin-13 receptor 111.7Y10179Prolactin-inducible protein 
600.9AL021155Brain Natriuretic Protein 101.8X02530IP-10§
530.6U49260Mevalonate pyrophosphate 
decarboxylase 
97.7J03037Human carbonic anhydrase I 
476.0L24564Ras associated with diabetes87.8X67325H.sapiens p27 mRNA
207.3AF051152Tol-like receptor 579.7AF016371U-snRNP-associated cyclophilin
206.1X81053Colagen type IV alpha 4 chain 72.1U70981Interleukin-13 receptor
197.0U54804Hyaluronan synthase 2 59.7D13666Osteoblast specific factor 2 
195.7AF056732Solute carier family 21 55.3AF053003Diphthamide biosynthesis protein-2
180.3AB020676KIAA0869 protein47.8U81234CKA-3
173.6AJ223728Porc-Pl gene similar to yeast CDC4539.9AJ242015Metaloproteinase-like, disintegrin-
like, cysteine-rich family I 
149.4U58917IL-17 receptor 38.7J05070Matrix metaloproteinase 9
147.6M74447Peptide supply factor-2 30.4X07834Superoxide dismutase 2
115.3AI865431Cluster Incl AI865431: wk11h09.x120.2U19557Human squamous cel carcinoma
antigen 2
111.1U20816Nuclear factor kappa-B218.6U77643K12 protein precursor 
106.8J03910Metalothionein-IG16.0AB002372KIAA0374 gene, syntaphilin 20p13
101.6M21121RANTES14.8X78565Tenascin-C
92.7AI148772Kynureninase14.3X79389Homo sapiens GSTT1 mRNA
92.5U19261Epstein-Bar virus-induced protein13.7X04430IFN-beta 2a 
73.2AB000734Tec-interacting proteins 313.6X62822Sialyltransferase 1
66.5U88964HEM4511.6M31165Tumor necrosis factor-inducible
protein (TSG-6) 
62.4M63193Platelet-derived endothelial cel 
growth factor 
10.2M28130IL8
49.2U04806FLT3/FLK2 ligand9.5AL049963BCG-induced gene in monocytes
45.7M30257Human vascular cel adhesion
molecule 1 
8.2X02910Tumor necrosis factor
32.6U58515Vhitinase8.0U64197LARC 
† The GeneBank accession number (htp:/www.ncbi.nlm.nih.gov/sites/entrez?db=Nucleotide) of each transcript is shown.
‡ The level of gene expression was obtained as the AD (average diference) using GeneChip® software. The percentages of the spe-
cific AD level versus the mean AD level of 6 probe sets for housekeeping genes (beta-actin and glyceraldehede-3-phosphate dehydroge-
nase) were then calculated. The fold increases of each experiment were averaged and are shown as the average fold increase.
§ Data indicating chemokine gene are underlined.
CHEMOKINE PRODUCTION FROM CORNEAL
EPITHELIAL CELLS AND FIBROBLASTS
Because the gene expression patterns between the
conjunctival and corneal cells were similar, we de-
cided to investigate chemokine production from the
corneal cells at the protein level, as assessed by
ELISA. We selected two CC chemokines (eotaxin-1,
which only increases in fibroblasts that are induced
upon stimulation, and MCP-1, which is more promi-
nently increased in fibroblasts and is constitutively
expressed) and two CXC chemokines (IP-10, which
increases in both epithelial cells and fibroblasts that
are inducible upon stimulation, and GRO-α, which in-
creases in both the epithelial cells and fibroblasts and
is constitutively expressed).
Eotaxin-1, MCP-1 and IP-10 production patterns in
the corneal epithelial cells and fibroblasts were com-
parable to the mRNA expression pattern, while the
Fukagawa K et al.
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Table 3 Fold increase of the chemokine transcripts in the corneal and conjunctival cels
Corneal 
fibroblasts
Corneal 
epithelial cels
Conjunctival 
fibroblasts
Conjunctival 
epithelial celsAccession 
number†
CHEMOKINES
FoldFoldFoldFold‡Name of transcript (protein)
0.50.70.91.0M57506I-309CCL1
2.21.63.42.1M28225MCP-1CCL2
1.30.81.91.1D90144MIP-1alphaCCL3
0.81.00.91.0J04130MIP-1betaCCL4
101.63.7843.89.9M21121RANTESCCL5
5.01.22.354.2X72308MCP-3CCL7
791.20.770.01.0Y16645MCP-2CCL8
5479.926.2132.71.6U46573eotaxinCCL11
12.728.415.60.8AJ001634MCP-4CCL13
0.81.00.17.9AF088219HCC-1CCL14
1.31.10.36.5AB018249LECCCL16
37.51.0371.54.5D43767TARCCCL17
4.21.00.52.4Y13710PARCCCL18
0.81.00.91.0AB000887ELCCCL19
6.38.022.71.2U64197LARCCCL20
0.81.00.91.0AB002409SLCCCL21
0.81.00.91.0U83171MDCCCL22
0.40.80.12.8AF088219MIP-3CCL23
1.53.60.868.6U86358TECKCCL25
0.81.00.966.9AJ243542CTACKCCL27
30.71.414.60.7U84487fracralkineCX3CL1
2.32.74.43.6X54489GRO-alphaCXCL1
3.52.35.81.3M36820GRO-betaCXCL2
6.54.114.20.6M36821GRO-gammaCXCL3
1.41.52.10.7M25897PF4CXCL4
4.25.22.31.3X78686ENA-78CXCL5
3.847.812.4344.2U81234CKA-3CXCL6
7.710.248.78.6M28130IL-8CXCL8
3.20.9325.01.0X72755MIGCXCL9
2124.9101.81694.78.5X02530IP-10CXCL10
1468.45.3944.33.0AF030514I-TACCXCL11
0.40.90.30.8L36033SDF-1bCXCL12
0.20.80.91.0AF044197BCLCXCL13
1.21.72.40.9L09230CCR1CCR1
1.40.71.51.0U03905MCP-1RBCCR2
4.80.70.50.7U28694CCR3CCR3
0.81.022.61.0X85740CCR4CCR4
5.30.50.98.5U95626CCR5
1.99.82.40.9U45984CCR6CCR6
0.20.95.61.3D49919CCR2CCR8
15.80.822.71.0AJ132337CCR9CCR9
1.30.90.81.2U94888CCR10CCR10
22.510.018.01.0AB008535CRTH2
0.83.540.60.0U20350CX3CR1
32.31.10.70.7U11870IL-8RACXCR1
0.82.91.70.6L19593IL-8RBCXCR2
32.31.01.01.5X95876CXCR3
0.17.9112.80.6L06797CXCR4
† The GeneBank accession number (htp:/www.ncbi.nlm.nih.gov/sites/entrez?db=Nucleotide) of each transcript is shown.
‡ The level of gene expression was obtained as the AD (average diference) using GeneChip® software. The percentages of the spe-
cific AD level versus the mean AD level of 6 probe sets for housekeeping genes (beta-actin and glyceraldehede-3-phosphate dehydroge-
nase) were then calculated. The primary cultured cels were incubated with IL-4 (30 ng/ml) and TNF-alpha (30 ng/ml) for 24 hr. Bald 
numerals stand for "presence" transcripts, which were judged by the GeneChip® software, while normal numerals stands for "marginal" or 
"absent" transcripts. Fold increase was obtained by calculating the AD levels of activated cels versus those of resting cels. Gray-colored 
columns mean "present" and over 3-fold increased transcripts. 
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Fig. 1 Eotaxin-1 production from corneal epithelial cels 
(A) and fibroblasts (B). Cels were incubated with IL-4 and 
TNF-α for 48 hours. Eotaxin-1 concentrations in the super-
natants were measured by ELISA. Data represent the 
mean±SD from three experiments.
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Fig. 2 MCP-1 production from corneal epithelial cels (A) 
and fibroblasts (B). Cels were incubated with IL-4 and TNF-
α for 48 hours. Eotaxin-1 concentrations in the supernatants 
were measured by ELISA. Data represent the mean±SD 
from three experiments.
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production pattern for GRO-α was slightly different
from its mRNA expression pattern. IL-4 induced
eotaxin-1 production and TNF-α enhanced eotaxin-1
production in fibroblasts but not in epithelial cells
(Fig. 1). The epithelial cells constitutively produced
small amounts of MCP-1, with marked increases
noted in the fibroblasts after TNF-α stimulation (Fig.
2). GRO-α was induced by TNF-α in the epithelial
cells, while it was constitutively produced by fibro-
blasts (Fig. 3). IP-10 was induced by TNF-α in both
cells (Fig. 4).
DISCUSSION
This is the first time that a comprehensive investiga-
tion has been undertaken on the chemokine gene ex-
pression in primary cultures of the four types of cells
that constitute the ocular surface; i.e., the corneal epi-
thelial cells, corneal fibroblasts, conjunctival epithe-
lial cells and conjunctival fibroblasts.
GeneChipⓇ is a high-density oligonucleotide ex-
pression probe array that is designed to measure the
absolute levels of >10,000 transcripts by using the
same set of inner standards. Since competition with
another cell types is not required for the
GeneChipⓇ,19 this makes it possible to be able to
compare expression levels of >10,000 transcripts in
different types of cells. In the current study, there
were three and six chemokine-associated genes listed
among the top 30 most increased genes for the con-
junctival epithelial cells and fibroblasts, respectively.
In the cornea, four and five chemokine-associated
genes were among the top 30 most increased genes
for the corneal epithelial cells and fibroblasts, respec-
tively. These findings indicate the importance of
chemokines in environments that are influenced by
IL-4 and TNF-α. CC chemokines were mostly induc-
ible and dominant in the fibroblasts, while CXC
chemokines were mostly constitutive and expressed
in both the epithelial cells and the fibroblasts.
Corneal tissue damage is among the most painful
and vision-threatening complication that is associated
with severe ocular allergic diseases such as atopic
keratoconjunctivitis (AKC)20,21 and vernal keratocon-
junctivitis (VKC).22,23 Eosinophils as well as eosino-
phil cationic protein (ECP) have been found in the
conjunctival tissue and in the tears of patients with
AKC and VKC.24,25 Eosinophil major basic protein
(MBP), which has been detected in corneal plaques
in VKC,26 was shown to inhibit epithelial migration.27
Therefore, eosinophils appear to participate in the
pathogenesis of corneal damage in ocular allergic dis-
eases. In addition, both CC chemokine-attracting in-
Fukagawa K et al.
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Fig. 3 GRO-α production from corneal epithelial cels (A) 
and fibroblasts (B). Cels were incubated with IL-4 and TNF-
α for 48 hours. Eotaxin-1 concentrations in the supernatants 
were measured by ELISA. Data represent the mean±SD 
from three experiments.
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Fig. 4 IP-10 production from corneal epithelial cels (A) 
and fibroblasts (B). Cels were incubated with IL-4 and TNF-
α for 48 hours. Eotaxin-1 concentrations in the supernatants 
were measured by ELISA. Data represent the mean±SD 
from three experiments.
Cont.
0.3 3
IL-4+TNF-alpha
30 0.3 0.33 330 30
IP
-1
0 
co
nc
en
tra
tio
n 
(p
g/
m
l)
1000
900
800
700
600
500
400
300
200
100
0
TNF-alphaIL-4(ng/ml)
Cont.
0.3 3
IL-4+TNF-alpha
30 0.3 0.33 330 30
IP
-1
0 
co
nc
en
tra
tio
n 
(p
g/
m
l)
1750
1500
1250
1000
750
500
250
0
TNF-alphaIL-4(ng/ml)
A
B
flammatory cells such as T-cells and basophils, and
CXC chemokine-attracting neutrophils have roles in
ocular allergic diseases.
CC chemokines such as eotaxin-128,29 and the pro-
tein RANTES30 are important in recruiting eosino-
phils into tissue affected by allergy. Eotaxin-1 has
been found in tears from allergic patients with severe
corneal damage, and has been shown to be corre-
lated with the number of eosinophils that are ob-
served in tears.11 We have also reported that inter-
leukin (IL)-4 induces eotaxin-1 production in human
corneal keratocytes but not in corneal epithelial
cells.5 In the current study, we found that corneal and
conjunctival fibroblasts induced CC chemokine gene
expression, while epithelial cells expressed only a few
CC chemokine transcripts. Corneal and conjunctival
fibroblasts may be a major source of the chemokines
that are responsible for recruiting eosinophils. In or-
der to prevent eosinophil infiltration of the ocular sur-
face, treatment strategies need to focus on regulating
the fibroblast chemokine production.
Our previous clinical experience has demonstrated
that while AKC and VKC without corneal epithelial le-
sions are relatively controllable, the disease becomes
more severe and is often refractory to treatment
when the corneal epithelial integrity is compromised.
Based on this clinical impression, the CC chemokine
expression pattern found in this study (which oc-
curred mainly in the fibroblasts and not in the epithe-
lial cells) led us to hypothesize that corneal epithelial
cells may act as a barrier against eosinophil recruit-
ment and severe tissue damage. Maintaining corneal
epithelial integrity in patients with severe ocular al-
lergy should therefore be considered to be an impor-
tant part of the treatment strategy in such diseases.
Eosinophils are attracted when chemokines inter-
act with the CC chemokine receptor (CCR)-1 and
CCR-3, which are located on their surfaces.31 While
RANTES activates eosinophils through both CCR-1
and CCR-3, eotaxin-1 is a specific ligand for CCR-3.32
We have previously reported that the anti-CCR-1 anti-
body (ab) and anti-CCR-3 ab are able to effectively, al-
though not completely, suppress the eosinophil che-
motaxis that is induced by the culture supernatant of
stimulated corneal fibroblasts.13 This incomplete sup-
pression suggests the existence of eosinophil
chemoattractants other than eotaxin-1 and RANTES.
In the current study, we noted that stimulation of the
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fibroblasts resulted in an increase of MCP-1, MCP-2
and IP-10, which are all known to be able to recruit
eosinophils. Since CCR-233 and CXCR334,35 have been
found to be located on the eosinophil surface, further
experiments are needed to investigate the interac-
tions of MCP-1CCR2, MCP-2CCR2 and IP-10
CXCR3. Liu et al. have found that BAL eosinophils,
but not blood eosinophils, are able to slightly express
CXCR3.35 This suggests that CXCR3 signaling is in-
volved in local inflammations, such as AKC and VKC.
Furthermore, while we found that the production of
GRO-α was inducible by TNF-α in corneal epithelial
cells, it was constitutive in the corneal fibroblasts.
These findings indicate that there is induction of lim-
ited GRO-α production in corneal epithelial cells
when inflammation occurs. Moreover, when the epi-
thelial damage is severe, production of GRO-α can
cause a much more intensive inflammation.
In this study, CC chemokines were mostly induc-
ible and selectively expressed in fibroblasts. CXC
chemokines were mostly constitutive and expressed
both in the epithelial cells and in the fibroblasts. CC
chemokines seem to have a more selective function
with regard to ocular allergic inflammation, while
CXC chemokines may have more of a general defen-
sive function against insults such as infections. LARC
and RANTES were the only two CC chemokines that
were constitutively expressed in the epithelial cells in
this study. LARC recruits T cells and dendritic cells
via CCR6,36,37 while RANTES attracts various inflam-
matory cells such as eosinophils, basophils, T cells,
monocytes, and dendritic cells, in addition to neutro-
phils via CCR1, 3, 4 and 5.30,38 Thus, these two CC
chemokines may have a more general function as
compared to the other CC chemokines.
MIG, IP-10 and I-TAC are the CXC chemokines
that are induced by interferon γ and attract T cells
bearing the specific receptor CXCR3. These chemoki-
nes have been reported to augment the inflammation
that occurs in atopic dermatitis.39 MIG has been re-
ported to play a role in T cell recruitment in VKC.40 In
the present study, MIG and I-TAC expressions were
inducible and selective in the fibroblasts, while all cell
types induced IP-10 expression. The T cell that re-
cruits the CXC chemokines that are induced in the fi-
broblasts may play a role in late-phase ocular allergic
inflammation.
We found only a few mRNA expressions for the
chemokine receptors in the conjunctival and corneal
cultured cells. In addition, only low mRNA expres-
sions of CCR3, CCR10 and CXCR3 were found, and
these were not subject to upregulation by any type of
stimulation. Thus, while chemokines may act on in-
flammatory cells, they do not act on any of the tissues
that constitute the ocular surface.
In conclusion, we were able to obtain a comprehen-
sive overview of chemokine and receptor expression
in cells that constitute the ocular surface. Corneal and
conjunctival fibroblasts exhibited marked increases
in the expression of chemokines upon stimulation.
Since fibroblasts exist on the ocular surface, they
may be one of the primary sources for the eosinophil-
recruiting chemokines that are present in allergic
conjunctival disease. Therefore, regulation of
chemokine production from the surface of such cells
might be an effective strategy for treating these dis-
eases.
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